Stella Chemifa Corporation

DB:SLO Stock Report

Market Cap: €290.4m

Stella Chemifa Valuation

Is SLO undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SLO when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SLO (€24) is trading below our estimate of fair value (€48.14)

Significantly Below Fair Value: SLO is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for SLO?

Key metric: As SLO is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for SLO. This is calculated by dividing SLO's market cap by their current earnings.
What is SLO's PE Ratio?
PE Ratio19.2x
EarningsJP¥2.42b
Market CapJP¥46.42b

Price to Earnings Ratio vs Peers

How does SLO's PE Ratio compare to its peers?

The above table shows the PE ratio for SLO vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average13.4x
UZU Uzin Utz
10.5x2.1%€250.2m
SIM0 SIMONA
11.2xn/a€345.0m
2HRA H&R GmbH KGaA
23.4x52.9%€129.2m
NTG Nabaltec
8.7x4.3%€123.2m
SLO Stella Chemifa
19.2x19.5%€46.4b

Price-To-Earnings vs Peers: SLO is expensive based on its Price-To-Earnings Ratio (19.2x) compared to the peer average (13.4x).


Price to Earnings Ratio vs Industry

How does SLO's PE Ratio compare vs other companies in the European Chemicals Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
SLO 19.2xIndustry Avg. 16.8xNo. of Companies12PE01224364860+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: SLO is expensive based on its Price-To-Earnings Ratio (19.2x) compared to the European Chemicals industry average (17.3x).


Price to Earnings Ratio vs Fair Ratio

What is SLO's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SLO PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio19.2x
Fair PE Ratio13.3x

Price-To-Earnings vs Fair Ratio: SLO is expensive based on its Price-To-Earnings Ratio (19.2x) compared to the estimated Fair Price-To-Earnings Ratio (13.3x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst SLO forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€24.00
€30.36
+26.5%
1.4%€30.79€29.93n/a2
Nov ’25€26.20
€30.78
+17.5%
1.4%€31.22€30.35n/a2
Oct ’25€25.20
€30.78
+22.1%
1.4%€31.22€30.35n/a2
Sep ’25€24.80
€30.78
+24.1%
1.4%€31.22€30.35n/a2
Aug ’25€24.40
€27.36
+12.1%
5.7%€28.91€25.81n/a2
Jun ’25€24.80
€24.19
-2.5%
10.8%€26.81€21.57n/a2
May ’25€22.40
€20.09
-10.3%
11.0%€22.31€17.87n/a2
Apr ’25€21.80
€20.09
-7.9%
11.0%€22.31€17.87n/a2
Mar ’25€22.60
€20.09
-11.1%
11.0%€22.31€17.87n/a2
Feb ’25€19.90
€20.09
+0.9%
11.0%€22.31€17.87n/a2
Jan ’25€20.20
€20.09
-0.6%
11.0%€22.31€17.87n/a2
Dec ’24€19.30
€20.09
+4.1%
11.0%€22.31€17.87n/a2
Nov ’24€19.50
€21.06
+8.0%
9.4%€23.04€19.09€26.202
Oct ’24€19.10
€21.06
+10.3%
9.4%€23.04€19.09€25.202
Sep ’24€19.30
€19.03
-1.4%
0.7%€19.16€18.90€24.802
Aug ’24€19.10
€20.47
+7.2%
0.7%€20.61€20.34€24.402
Jul ’24€19.30
€20.47
+6.1%
0.7%€20.61€20.34€24.402
Jun ’24€19.30
€20.47
+6.1%
0.7%€20.61€20.34€24.802
May ’24€17.60
€22.70
+29.0%
7.0%€24.29€21.10€22.402
Apr ’24€17.70
€22.70
+28.2%
7.0%€24.29€21.10€21.802
Jan ’24€17.10
€32.55
+90.3%
18.9%€38.69€26.40€20.202
Dec ’23€17.80
€32.55
+82.8%
18.9%€38.69€26.40€19.302
Nov ’23€17.80
€35.13
+97.4%
15.2%€40.47€29.79€19.502

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.


Discover undervalued companies